Our analysis of the CGGA and TCGA databases suggested that RPP30 was enriched in GBM samples with TP53 mutation and IDH1 Mutation, but was unrelated to EGFR amplification status in (Figure 4A, 4C). This evidence concerns the gene RPP30 and glioblastoma.